DrugsControl Media Services

News Detail

DTAB refuses to revoke ban on FDC of vitamin B1, B6 and B12 (29-06-2023)

New Delhi, 29 June 2023: The Drugs Technical Advisory Board (DTAB) has refused to revoke the prohibition on the use of the fixed dose combination (FDC) of vitamin B1, B6 and B12, as against a representation from a multinational pharmaceutical company in the country, noting that t......
View Details

Source : Pharmabiz
DTAB revoke prohibition FDC vitamin B1 vitamin B6 vitamin B12 CDSCO P&G carpal tunnel syndrome alcohol abuse autoimmune diseases rheumatoid arthritis chronic inflammation neurotrophic DCGI

Related News